Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Futile medicai treatment and patient consent
    Martin L. Smith, STD
    Cleveland Clinic Journal of Medicine March 1993, 60 (2) 151-154;

    What are a physician’s ethical responsibilities when a patient or surrogate demands futile life-saving treatment?

  • You have access
    Epilepsy and Sudden Death by Lathers CH, Schraeder PL
    Prakash Kotagal, MD
    Cleveland Clinic Journal of Medicine March 1993, 60 (2) 72;
  • You have access
    Selective bowel decontamination with quinolones and nystatin reduces gram-negative and fungal infections in orthotopic liver transplant recipients
    Margaret J. Gorensek, MD, William D. Carey, MD, John A. Washington, MD, David P. Vogt, MD, Thomas A. Broughan, MD and Mary Kay Westveer, RN
    Cleveland Clinic Journal of Medicine March 1993, 60 (2) 139-144;

    This regimen was found highly effective in reducing early serious infection in 17 consecutive patients.

  • You have access
    Geriatric Nutrition: a Comprehensive Review ed. by John E. Morley, MB, BCh; Zvi Glick, PhD; Lawrence Z. Rubenstein, MD
    Dennis W. Jahnigen, MD
    Cleveland Clinic Journal of Medicine March 1993, 60 (2) 72;
  • You have access
    Highlights from medical grand rounds
    Cleveland Clinic Journal of Medicine March 1993, 60 (2) 101-102;

    Recent evidence from long-term studies contradicts the perception that rheumatoid arthritis is slowly progressive, relatively benign, and readily controlled with monotherapy.

  • You have access
    Epilepsy: Current Approaches to Diagnosis and Treatment ed. by Dennis B. Smith, MD
    Robert S. Flint, MD, PhD and Prakash Kotagal, MD
    Cleveland Clinic Journal of Medicine March 1993, 60 (2) 72;
  • You have access
    Monoamine oxidase inhibitors and elective surgery
    Zeyd Y. Ebrahim, MD, Jerome O’Hara, MD, Lester Borden, MD and John Tetzlaff, MD
    Cleveland Clinic Journal of Medicine March 1993, 60 (2) 129-130;

    This retrospective study of 32 patients challenges the notion that use of these agents is a contraindication for elective surgery.

  • You have access
    Vitamin Intake and Health: a Scientific Review by Suzanne K. Gaby, Adrianne Bendich, Vishwa Singh, and Lawrence J. Machlin
    Larry M. Kohse, MD
    Cleveland Clinic Journal of Medicine March 1993, 60 (2) 72;
  • You have access
    Potential molecular therapy for acute renal failure
    H. David Humes, MD
    Cleveland Clinic Journal of Medicine March 1993, 60 (2) 166-168;

    As more is learned about renal epithelial cell regeneration and differentiation, exogenously administered growth promoters seem a likely intervention.

  • You have access
    Bullectomies for bullous sarcoidosis
    Cesar M. Pena, MD, Delos M. Cosgrove, MD, Philip Eng, MD, Thomas Kirby, MD, Thomas Rice, MD and Atul C. Mehta, MD
    Cleveland Clinic Journal of Medicine March 1993, 60 (2) 157-160;

Pages

  • Previous
  • Next
  • 1
  • …
  • 485
  • 486
  • 487
  • 488
  • 489
  • 490
  • 491
  • 492
  • 493
  • …
  • 798

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire